Endocrinology, Vol 127, 738-746, Copyright © 1990 by Endocrine Society

ARTICLES

Generation of regulatory oxysterols: 26-hydroxylation of cholesterol by ovarian mitochondria

H Rennert, RT Fischer, JG Alvarez, JM Trzaskos and JF Strauss 3d
Department of Obstetrics and Gynecology, University of Pennsylvania, School of Medicine, Philadelphia 19104.

De novo synthesis of cholesterol and low-density lipoprotein (LDL) receptor levels are suppressed in the presence of cholesterol. Recent evidence suggests that a cholesterol metabolite (possibly a hydroxysterol), not cholesterol per se, is the effector that inhibits transcription of genes encoding enzymes involved in sterol synthesis and LDL receptors. We found that 26-hydroxycholesterol inhibits human ovarian cell sterol synthesis, and that luteinized human granulosa cells contain 26-hydroxylase messenger RNA (mRNA). We proceeded to characterize the enzyme generating 26-hydroxycholesterol in the rat ovary. Mitochondria derived from ovaries of PMSG-human CG (hCG) primed immature rats (day 3 post-hCG) metabolized [3H] cholesterol into [3H]26- hydroxycholesterol in the presence of nicotinamide adenine dinucleotide phosphate and aminoglutethimide (100 micrograms/ml), added to inhibit metabolism of sterols by the cholesterol side-chain cleavage system. The identity of the product was confirmed by chromatography in several systems; recrystallization to constant specific activity and mass spectrometry. Negligible 26-hydroxylase activity was detected in other ovarian subcellular fractions. 26-Hydroxycholesterol formation progressed at a linear rate for up to 40 min and was linearly related to mitochondrial protein added to the incubation mixture. 26- Hydroxylase was markedly stimulated (5-fold) by calcium (0.2 mM). Maximal rates of 26-hydroxycholesterol formation observed were 1 pmol/min.mg protein. This activity is substantially lower than cholesterol side-chain cleavage measured in the absence of aminoglutethimide. Ketoconazole (1-100 microM) inhibited 26-hydroxylase in a dose-dependent manner. Pregnenolone (1-1000 microM) and progesterone (1-100 microM) inhibited 26-hydroxylase in a dose- dependent manner, with appreciable inhibitory effects in the 1-10 microM range. We suggest that 26-hydroxycholesterol is an intracrine regulator that controls cellular sterol metabolism. Formation of 26- hydroxcholesterol in ovarian cells may be regulated by steroidogenic activity in such a way as to ensure availability of steroid hormone precursors. When steroidogenesis is active, 26-hydroxylase is inhibited by products of the side-chain cleavage system, allowing increased de novo sterol synthesis and LDL uptake. With reduced steroidogenic activity and less demand for cholesterol, 26-hydroxylase is not blocked, permitting formation of 26-hydroxycholesterol with attendant reduction in sterol synthesis and LDL receptor gene expression.

This article has been cited by other articles:

				Y. Ota, T.-A. Eto, S.-I. Tanaka, H. Sueta, H. Shiotsuki, Y. Maeda, M. Une, and K. Chijiiwa Assay method for mitochondrial sterol 27-hydroxylase with 7{alpha}-hydroxy-4-cholesten-3-one as a substrate in the rat liver J. Lipid Res., December 1, 2003; 44(12): 2400 - 2405. [Abstract] [Full Text] [PDF]

				F. J. Field, E. Born, S. Murthy, and S. N. Mathur Regulation of sterol regulatory element-binding proteins by cholesterol flux in CaCo-2 cells J. Lipid Res., October 1, 2001; 42(10): 1687 - 1698. [Abstract] [Full Text] [PDF]

				B. D. Murphy Models of Luteinization Biol Reprod, July 1, 2000; 63(1): 2 - 11. [Abstract] [Full Text]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				S. Yoshida, K. Kubota, H. Sasaki, T. Hasegawa, M. Nishihara, M. Terada, and M. Takahashi 26-Cholesterol Hydroxylase in Rat Corpora Lutea: A Negative Regulator of Progesterone Secretion Biol Reprod, September 1, 1999; 61(3): 557 - 562. [Abstract] [Full Text]

				L. K. Christenson, J. M. McAllister, K. O. Martin, N. B. Javitt, T. F. Osborne, and J. F. Strauss III Oxysterol Regulation of Steroidogenic Acute Regulatory Protein Gene Expression. STRUCTURAL SPECIFICITY AND TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL ACTIONS J. Biol. Chem., November 13, 1998; 273(46): 30729 - 30735. [Abstract] [Full Text] [PDF]

				D. S. Lala, P. M. Syka, S. B. Lazarchik, D. J. Mangelsdorf, K. L. Parker, and R. A. Heyman Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols PNAS, May 13, 1997; 94(10): 4895 - 4900. [Abstract] [Full Text] [PDF]

				D. W. Payne, C. Shackleton, H. Toms, I. Ben-Shlomo, S. Kol, M. deMoura, J. F. Strauss, and E. Y. Adashi A Novel Nonhepatic Hydroxycholesterol 7alpha-Hydroxylase That Is Markedly Stimulated by Interleukin-1beta J. Biol. Chem., August 11, 1995; 270(32): 18888 - 18896. [Abstract] [Full Text] [PDF]

				J. J. Repa, E. G. Lund, J. D. Horton, E. Leitersdorf, D. W. Russell, J. M. Dietschy, and S. D. Turley Disruption of the Sterol 27-Hydroxylase Gene in Mice Results in Hepatomegaly and Hypertriglyceridemia. REVERSAL BY CHOLIC ACID FEEDING J. Biol. Chem., December 8, 2000; 275(50): 39685 - 39692. [Abstract] [Full Text] [PDF]